SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-22-007951
Filing Date
2022-04-01
Accepted
2022-04-01 07:05:34
Documents
14
Period of Report
2022-03-31
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K arav20220331_8k.htm   iXBRL 8-K 26202
2 EXHIBIT 99.1 ex_354023.htm EX-99.1 11873
  Complete submission text file 0001437749-22-007951.txt   178827

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA arav-20220331.xsd EX-101.SCH 3602
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arav-20220331_def.xml EX-101.DEF 11920
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE arav-20220331_lab.xml EX-101.LAB 15967
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arav-20220331_pre.xml EX-101.PRE 12131
8 EXTRACTED XBRL INSTANCE DOCUMENT arav20220331_8k_htm.xml XML 2655
Mailing Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098
Business Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098 936-355-1910
Aravive, Inc. (Filer) CIK: 0001513818 (see all company filings)

IRS No.: 264106690 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36361 | Film No.: 22795802
SIC: 2834 Pharmaceutical Preparations